MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202617081712 A) filed by Janssen Biotech, Inc. on July 02, 2026, for Cd33 Antibodies, Cd33/Vd2 Multispecific Antibodies And Uses Thereof.
Inventors include Elashkar, Sara Mohamed A; Kallal, Lorena A; Jacobs, Steven A.; Philippar, Ulrike; Doonan, Patrick John Application Number; Parren, Paul Willem Henri Ida; Merat, Sabrina Julia Louisa; Roovers, Robertus Cornelis Number; Van Der Vliet, Johannes Jelle; and Van Helden, Paula Maria Wilhelmina.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: CD33 antibodies, and antigen-binding fragments thereof, and CD33/Vd2 multispecific antibodies, or antigen- binding fragments thereof, are described. Also described are polynucleotides encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies for treating or preventing diseases, such as hematological cancers.
Disclaimer: Curated by HT Syndication.
